The Prevalence of COVID-19 in Europe by the End of November 2022: A Cross-Sectional Study

被引:9
|
作者
Alrasheedi, Ahmad A. [1 ]
机构
[1] Qassim Univ, Dept Family & Community Med, Buraydah, Saudi Arabia
关键词
median age; vaccine; testing; european union; europe; covid-19; coronavirus; case-fatality; SARS-COV-2;
D O I
10.7759/cureus.33546
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The world has been affected differently by the coronavirus disease 2019 (COVID-19), and Europe reaped the largest number of cases and deaths. Moreover, COVID-19 statistics are dynamic. Objectives The current study aimed to use COVID-19 data to examine the COVID-19 prevalence in Europe by the end of November 2022 and compare the findings globally. Methods The primary data on COVID-19 for each European country were obtained from the "Worldometer" website. The data include the cumulative incidence of COVID-19 per country, the cumulative number of deaths, the total number of tests performed, the number of cases per million population, the number of deaths per million, the number of tests per million, and the total population. The case-fatality rate was calculated (number of deaths/number of cases). In addition, the median age and the vaccination coverage rate (people who received two doses) for each European country were extracted from the "United Nations" website and the "Our World in Data" website, respectively. To compare European countries to the globe, COVID-19 data for each continent were obtained. The analysis of variance (ANOVA) test was used to compare variances across the means of the four parts of Europe based on the geographic division. An independent sample t-test was also used to compare the means between the European Union (EU) states and non-EU states. The Spearman correlation coefficient was used to determine the relationship between different variables across Europe. Results As of December 1, 2022, about 648 million COVID-19 cases and 6.6 million deaths have been recorded worldwide. Europe accounted for nearly 36.8% and 29.5% of all cases and deaths, respectively. Based on the number of deaths per million, Europe was the most affected continent after South America. Nearly 6.8 billion tests have been conducted worldwide, 41% done in Europe; 43 European countries have performed tests more than their population. However, COVID-19 statistics were inconsistent across the four parts of Europe. A significant difference was noticed between Eastern Europe and others, especially Northern Europe and Western Europe. By affiliation with the EU, there was no significant difference. For global comparison, the mean deaths per million, the mean cases per million, and the mean tests per population for European countries were higher than those of the world's countries, although they recorded a lower mean case-fatality rate (CFR). Thirteen European countries were among the 15 most affected countries worldwide based on the number of deaths per million, most located in Eastern and Southern Europe. The number of cases and the number of deaths were significantly proportional to the number of tests performed. Conclusions By the end of November 2022, Europe had the most cases of COVID-19, the most deaths, and the most tests performed, even though it accounts for 9.4% of the world's population. However, COVID-19 data were inconsistent across the four parts of Europe, especially between Eastern Europe and others. Given the natural immunity acquired during the three years and the excellent vaccine coverage in Europe, it is essential to reconsider the definition of a suspected case and establish more specific criteria for testing.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] COVID-19 Statistics in the Arab World by the End of October 2022: A Cross-Sectional Study
    Alrasheedi, Ahmad A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (12)
  • [2] Analysis of COVID-19 Prevalence in Africa Based on the Geographic Division and Income by the End of 2022: A Cross-Sectional Study
    Alrasheedi, Ahmad Ali
    BAHRAIN MEDICAL BULLETIN, 2023, 45 (03) : 1632 - 1639
  • [3] Cross-Sectional Study of Prevalence of COVID-19 in Alkharj, Saudi Arabia
    Ahmed, Nehad J.
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2020, 32 (20) : 184 - 188
  • [4] Impact of COVID-19 on the prevalence of dyslipidemia in Ecuador: A cross-sectional study between 2017 and 2022
    Rivadeneira, Josue
    Fuenmayor-Gonzalez, Luis
    Jacome-Garcia, Michelle
    Flores-Lastra, Nancy
    Delgado, Hugo
    Otzen, Tamara
    ATENCION PRIMARIA, 2025, 57 (04):
  • [5] Household Transmission of COVID-19: A Cross-Sectional Study
    Dutta, Siddhartha
    Kaur, Rimple Jeet
    Bhardwaj, Pankaj
    Charan, Jaykaran
    Bist, Sunil Kumar Singh
    Detha, Mohan Dan
    Kanchan, Tanuj
    Sharma, Praveen
    Misra, Sanjeev
    INFECTION AND DRUG RESISTANCE, 2020, 13 : 4637 - 4642
  • [6] PREVALENCE AND OUTCOMES OF DIABETES AMONG COVID-19 PATIENTS IN DUHOK COVID-19 HEALTH FACILITIES: A CROSS-SECTIONAL STUDY
    Hussein, Hozan Qasim
    Salih, Ahmed Mohamed
    Merza, Muayad Aghali
    HEALTH PROBLEMS OF CIVILIZATION, 2023, 17 (01) : 24 - 35
  • [7] The prevalence of anosmia among patients with COVID-19 in Istanbul, Turkey: A cross-sectional study
    Celikoyar, M. Mazhar
    Kavlakoglu, Nail
    Inan, Basak Oguz
    Guden, Ege Can
    Ruzgar, Ummahan Rumeysa
    Aycicek, Ozlem Kurnaloglu
    Donmeze, Tolga
    Aktan, Erkan
    B-ENT, 2021, 17 (01) : 24 - 30
  • [8] Predictors of intention to get COVID-19 vaccine: A cross-sectional study
    Al-Rawashdeh, Sami
    Rababa, Mohammad
    Rababa, Majdi
    Hamaideh, Shaher
    NURSING FORUM, 2022, 57 (02) : 277 - 287
  • [9] Prevalence and Predictive Factors of Rhabdomyolysis in COVID-19 Patients: A Cross-sectional Study
    Hashemi, Behrooz
    Farhangi, Nader
    Toloui, Amirmohammad
    Alavi, Seyedeh N. R.
    Forouzanfar, Mohammad M.
    Ramawad, Hamzah A.
    Safari, Saeed
    Yousefifard, Mahmoud
    INDIAN JOURNAL OF NEPHROLOGY, 2024, 34 (02) : 144 - 148
  • [10] Comparison of COVID-19 Outcomes With Alpha-1 Antitrypsin Deficiency Prevalence in Europe: A Cross-Sectional Study
    Sezgin, Yilmaz
    Becel, Sinan
    Kaplan, Askin K.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (01)